|
1
|
Boutari C and Mantzoros CS: A 2022 update
on the epidemiology of obesity and a call to action: As its twin
COVID-19 pandemic appears to be receding, the obesity and
dysmetabolism pandemic continues to rage on. Metabolism.
133:1552172022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Younossi ZM, Koenig AB, Abdelatif D, Fazel
Y, Henry L and Wymer M: Global epidemiology of nonalcoholic fatty
liver disease-Meta-analytic assessment of prevalence, incidence,
and outcomes. Hepatology. 64:73–84. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Noureddin M, Vipani A, Bresee C, Todo T,
Kim IK, Alkhouri N, Setiawan VW, Tran T, Ayoub WS, Lu SC, et al:
NASH leading cause of liver transplant in women: Updated analysis
of indications for liver transplant and ethnic and gender
variances. Am J Gastroenterol. 113:1649–1659. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baffy G, Brunt EM and Caldwell SH:
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An
emerging menace. J Hepatol. 56:1384–1391. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Geng Y, Faber KN, de Meijer VE, Blokzijl H
and Moshage H: How does hepatic lipid accumulation lead to
lipotoxicity in non-alcoholic fatty liver disease? Hepatol Int.
15:21–35. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bugianesi E, Moscatiello S, Ciaravella MF
and Marchesini G: Insulin resistance in nonalcoholic fatty liver
disease. Curr Pharm Des. 16:1941–1951. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rada P, Gonzalez-Rodriguez A,
Garcia-Monzon C and Valverde AM: Understanding lipotoxicity in
NAFLD pathogenesis: Is CD36 a key driver? Cell Death Dis.
11:8022020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Listenberger LL, Han X, Lewis SE, Cases S,
Farese RV Jr, Ory DS and Schaffer JE: Triglyceride accumulation
protects against fatty Acid-induced lipotoxicity. Proc Natl Acad
Sci USA. 100:3077–3082. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tripathy D, Mohanty P, Dhindsa S, Syed T,
Ghanim H, Aljada A and Dandona P: Elevation of free fatty acids
induces inflammation and impairs vascular reactivity in healthy
subjects. Diabetes. 52:2882–2887. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hommelberg PP, Plat J, Langen RC, Schols
AM and Mensink RP: Fatty Acid-induced NF-kappaB activation and
insulin resistance in skeletal muscle are chain length dependent.
Am J Physiol Endocrinol Metab. 296:E114–E120. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li D, Yang SG, He CW, Zhang ZT, Liang Y,
Li H, Zhu J, Su X, Gong Q and Xie Z: Excess diacylglycerol at the
endoplasmic reticulum disrupts endomembrane homeostasis and
autophagy. BMC Biol. 18:1072020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shi H, Kokoeva MV, Inouye K, Tzameli I,
Yin H and Flier JS: TLR4 links innate immunity and fatty
acid-induced insulin resistance. J Clin Invest. 116:3015–3025.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gassaway BM, Petersen MC, Surovtseva YV,
Barber KW, Sheetz JB, Aerni HR, Merkel JS, Samuel VT, Shulman GI
and Rinehart J: PKCε contributes to lipid-induced insulin
resistance through cross talk with p70S6K and through previously
unknown regulators of insulin signaling. Proc Natl Acad Sci USA.
115:E8996–E9005. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tabas I: Free cholesterol-induced
cytotoxicity a possible contributing factor to macrophage foam cell
necrosis in advanced atherosclerotic lesions. Trends Cardiovasc
Med. 7:256–263. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tabas I: Consequences of cellular
cholesterol accumulation: Basic concepts and physiological
implications. J Clin Invest. 110:905–911. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Song Y, Liu J, Zhao K, Gao L and Zhao J:
Cholesterol-induced toxicity: An integrated view of the role of
cholesterol in multiple diseases. Cell Metab. 33:1911–1925. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kong FJ, Wu JH, Sun SY and Zhou JQ: The
endoplasmic reticulum stress/autophagy pathway is involved in
cholesterol-induced pancreatic beta-cell injury. Sci Rep.
7:447462017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gan LT, Van Rooyen DM, Koina ME, McCuskey
RS, Teoh NC and Farrell GC: Hepatocyte free cholesterol
lipotoxicity results from JNK1-mediated mitochondrial injury and is
HMGB1 and TLR4-dependent. J Hepatol. 61:1376–1384. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pu D, Tan R, Yu Q and Wu J: Metabolic
syndrome in menopause and associated factors: A meta-analysis.
Climacteric. 20:583–591. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Janssen I, Powell LH, Crawford S, Lasley B
and Sutton-Tyrrell K: Menopause and the metabolic syndrome: The
Study of Women's Health Across the Nation. Arch Intern Med.
168:1568–1575. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rodriguez-Rodriguez AE, Donate-Correa J,
Luis-Lima S, Diaz-Martin L, Rodriguez-Gonzalez C, Perez-Perez JA,
Acosta-González NG, Fumero C, Navarro-Díaz M, López-Álvarez D, et
al: Obesity and metabolic syndrome induce hyperfiltration,
glomerulomegaly, and albuminuria in obese ovariectomized female
mice and obese male mice. Menopause. 28:1296–1306. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stevenson JC: Metabolic effects of hormone
replacement therapy. J Br Menopause Soc. 10:157–161. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Afonso-Ali A, Porrini E, Teixido-Trujillo
S, Perez-Perez JA, Luis-Lima S, Acosta-Gonzalez NG, Sosa-Paz I,
Díaz-Martín L, Rodríguez-González C and Rodríguez-Rodríguez AE: The
role of gender differences and menopause in Obesity-related renal
disease, renal inflammation and lipotoxicity. Int J Mol Sci.
24:129842023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bedossa P, Poitou C, Veyrie N, Bouillot
JL, Basdevant A, Paradis V, Tordjman J and Clement K:
Histopathological algorithm and scoring system for evaluation of
liver lesions in morbidly obese patients. Hepatology. 56:1751–1759.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Christie WW: Gas Chromatography and
Lipids: A practical guide. Oily Press; 1989
|
|
26
|
Olsen RE and Henderson RJ: The rapid
analysis of neutral and polar marine lipids using
double-development HPTLC and scanning densitometry. J Exp Mar Bio
Ecol. 129:189–197. 1989. View Article : Google Scholar
|
|
27
|
Echeverria F, Valenzuela R, Bustamante A,
Alvarez D, Ortiz M, Espinosa A, Illesca P, Gonzalez-Mañan D and
Videla LA: High-fat diet induces mouse liver steatosis with a
concomitant decline in energy metabolism: Attenuation by
eicosapentaenoic acid (EPA) or hydroxytyrosol (HT) supplementation
and the additive effects upon EPA and HT co-administration. Food
Funct. 10:6170–6183. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sanyal AJ, Williams SA, Lavine JE,
Neuschwander-Tetri BA, Alexander L, Ostroff R, Biegel H, Kowdley
KV, Chalasani N, Dasarathy S, et al: Defining the serum proteomic
signature of hepatic steatosis, inflammation, ballooning and
fibrosis in non-alcoholic fatty liver disease. J Hepatol.
78:693–703. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Teng X and Wang Y: Diacylglycerols as
lipid mediators in metabolic diseases: Insights from their role in
insulin resistance. Mol Metabolism. 21:86–98. 2019.
|
|
30
|
Bays HE and Tressler JA: Lipotoxicity: A
review of the relationship between obesity, type 2 diabetes, and
non-alcoholic fatty liver disease. J Clin Endocrinol Metabolism.
95:415–425. 2010.
|
|
31
|
Palmisano BT, Zhu L and Stafford JM: Role
of estrogens in the regulation of liver lipid metabolism.
Homeostasis, Diabetes and Obesity, Advances in Experimental
Medicine and Biology 1043. Springer International Publishing AG;
pp. 227–256. 2017
|
|
32
|
Shama S, Jang H, Wang X, Zhang Y, Shahin
NN, Motawi TK, Kim S, Gawrieh S and Liu W:
Phosphatidylethanolamines are associated with nonalcoholic fatty
liver disease (NAFLD) in obese adults and induce liver cell
metabolic perturbations and hepatic stellate cell activation. Int J
Mol Sci. 24:10342023. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Puri P, BaillieR A, Wiest MM, Mirshahi F,
Choudhury J, Cheung O, Sargeant C, Contos MJ and Sanyal AJ: A
lipidomic analysis of nonalcoholic fatty liver disease. Hepatology.
46:1081–1090. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Haas JT, Miao J, Chanda D, Wang Y, Zhao E,
Haas ME, Hirschey M, Vaitheesvaran B, Farese RV Jr, Kurland IJ, et
al: Hepatic insulin signaling is required for obesity-dependent
expression of SREBP-1c mRNA but not for feeding-dependent
expression. Cell Metab. 15:873–884. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Czech MP, Tencerova M, Pedersen DJ and
Aouadi M: Insulin signaling mechanisms for triacylglycerol storage.
Diabetologia. 56:949–964. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
O'Rourke L, Gronning LM, Yeaman SJ and
Shepherd PR: Glucose-dependent regulation of cholesterol ester
metabolism in macrophages by insulin and leptin. J Biol Chem.
277:42557–42562. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Laplante M and Sabatini DM: An emerging
role of mTOR in lipid biosynthesis. Curr Biol. 19:R1046–R1052.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chitraju C, Mejhert N, Haas JT,
Diaz-Ramirez LG, Grueter CA, Imbriglio JE, Pinto S, Koliwad SK,
Walther TC and Farese RV Jr: Triglyceride synthesis by DGAT1
protects adipocytes from Lipid-induced ER stress during lipolysis.
Cell Metab. 26:407–18.e3. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kellner-Weibel G, Jerome WG, Small DM,
Warner GJ, Stoltenborg JK, Kearney MA, Corjay MH, Phillips MC and
Rothblat GH: Effects of intracellular free cholesterol accumulation
on macrophage viability: A model for foam cell death. Arterioscler
Thromb Vasc Biol. 18:423–4231. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ly LD, Xu S, Choi SK, Ha CM, Thoudam T,
Cha SK, Wiederkehr A, Wollheim CB, Lee IK and Park KS: Oxidative
stress and calcium dysregulation by palmitate in type 2 diabetes.
Exp Mol Med. 49:e2912017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Warner GJ, Stoudt G, Bamberger M, Johnson
WJ and Rothblat GH: Cell toxicity induced by inhibition of acyl
coenzyme A: Cholesterol acyltransferase and accumulation of
unesterified cholesterol. J Biol Chem. 270:5772–5778. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bosma M, Dapito DH, Drosatos-Tampakaki Z,
Huiping-Son N, Huang LS, Kersten S, Drosatos K and Goldberg IJ:
Sequestration of fatty acids in triglycerides prevents endoplasmic
reticulum stress in an in vitro model of cardiomyocyte
lipotoxicity. Biochim Biophys Acta. 1841:1648–1655. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gupte AA, Pownall HJ and Hamilton DJ:
Estrogen: An emerging regulator of insulin action and mitochondrial
function. J Diabetes Res. 2015:9165852015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhu L, Brown WC, Cai Q, Krust A, Chambon
P, McGuinness OP and Stafford JM: Estrogen treatment after
ovariectomy protects against fatty liver and may improve
pathway-selective insulin resistance. Diabetes. 62:424–434. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yan H, Yang W, Zhou F, Li X, Pan Q, Shen
Z, Han G, Newell-Fugate A, Tian Y, Majeti R, et al: Estrogen
improves insulin sensitivity and suppresses gluconeogenesis via the
transcription factor foxo1. Diabetes. 68:291–304. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
De Paoli M, Zakharia A and Werstuck GH:
The role of estrogen in insulin resistance: A review of clinical
and preclinical data. Am J Pathol. 191:1490–1498. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cuadros JL, Fernandez-Alonso AM, Chedraui
P, Cuadros AM, Sabatel RM and Perez-Lopez FR: Metabolic and
hormonal parameters in post-menopausal women 10 years after
transdermal oestradiol treatment, alone or combined to micronized
oral progesterone. Gynecol Endocrinol. 27:156–162. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Os I, Os A, Abdelnoor M, Larsen A,
Birkeland K and Westheim A: Insulin sensitivity in women with
coronary heart disease during hormone replacement therapy. J Womens
Health (Larchmt). 14:137–145. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Soranna L, Cucinelli F, Perri C, Muzj G,
Giuliani M, Villa P and Lanzone A: Individual effect of E2 and
dydrogesterone on insulin sensitivity in post-menopausal women. J
Endocrinol Invest. 25:547–550. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhu L, Martinez MN, Emfinger CH, Palmisano
BT and Stafford JM: Estrogen signaling prevents diet-induced
hepatic insulin resistance in male mice with obesity. Am J Physiol
Endocrinol Metab. 306:E1188–E1197. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Dashti N, Kelley JL, Thayer RH and Ontko
JA: Concurrent inductions of avian hepatic lipogenesis, plasma
lipids, and plasma apolipoprotein B by estrogen. J Lipid Res.
24:368–380. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Rogers NH, Perfield JW II, Strissel KJ,
Obin MS and Greenberg AS: Reduced energy expenditure and increased
inflammation are early events in the development of
ovariectomy-induced obesity. Endocrinology. 150:2161–2168. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ludgero-Correia A Jr, Aguila MB,
Mandarim-de-Lacerda CA and Faria TS: Effects of high-fat diet on
plasma lipids, adiposity, and inflammatory markers in
ovariectomized C57BL/6 mice. Nutrition. 28:316–323. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kamei Y, Suzuki M, Miyazaki H,
Tsuboyama-Kasaoka N, Wu J, Ishimi Y and Ezaki O: Ovariectomy in
mice decreases lipid metabolism-related gene expression in adipose
tissue and skeletal muscle with increased body fat. J Nutr Sci
Vitaminol (Tokyo). 51:110–117. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ozbey N, Sencer E, Molvalilar S and Orhan
Y: Body fat distribution and cardiovascular disease risk factors in
pre- and postmenopausal obese women with similar BMI. Endocr J.
49:503–509. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ambikairajah A, Walsh E and Cherbuin N:
Lipid profile differences during menopause: A review with
meta-analysis. Menopause. 26:1327–1333. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zadoorian A, Du X and Yang H: Lipid
droplet biogenesis and functions in health and disease. Nat Rev
Endocrinol. 19:443–459. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Olzmann JA and Carvalho P: Dynamics and
functions of lipid droplets. Nat Rev Mol Cell Biol. 20:137–155.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Nosadini R and Tonolo G: Role of oxidized
low density lipoproteins and free fatty acids in the pathogenesis
of glomerulopathy and tubulointerstitial lesions in type 2
diabetes. Nutr Metab Cardiovasc Dis. 21:79–85. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Shen T, Li X, Jin B, Loor JJ, Aboragah A,
Ju L, Fang Z, Yu H, Chen M, Zhu Y, et al: Free fatty acids impair
autophagic activity and activate nuclear factor kappa B signaling
and NLR family pyrin domain containing 3 inflammasome in calf
hepatocytes. J Dairy Sci. 104:11973–1182. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Li Y, Schwabe RF, DeVries-Seimon T, Yao
PM, Gerbod-Giannone MC, Tall AR, Davis RJ, Flavell R, Brenner DA
and Tabas I: Free cholesterol-loaded macrophages are an abundant
source of tumor necrosis factor-alpha and interleukin-6: Model of
NF-kappaB- and map kinase-dependent inflammation in advanced
atherosclerosis. J Biol Chem. 280:21763–21772. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Cheng J, Montecalvo A and Kane LP:
Regulation of NF-κB induction by TCR/CD28. Immunol Res. 50:113–117.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Di Marzo V: Arachidonic acid and
eicosanoids as targets and effectors in second messenger
interactions. Prostaglandins Leukot Essent Fatty Acids. 53:239–254.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Brien M, Berthiaume L, Rudkowska I, Julien
P and Bilodeau JF: Placental dimethyl acetal fatty acid derivatives
are elevated in preeclampsia. Placenta. 51:82–88. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Bozelli JC Jr, Azher S and Epand RM:
Plasmalogens and chronic inflammatory diseases. Front Physiol.
12:7308292021. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Brenner RR: Nutritional and hormonal
factors influencing desaturation of essential fatty acids. Prog
Lipid Res. 20:41–47. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Cook HW: The influence of trans-acids on
desaturation and elongation of fatty acids in developing brain.
Lipids. 16:920–926. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Chena X, Lia L, Liua X, Luoa R, Liaob G,
Lia L, Liua J, Chenga J, Lua Y and Chen Y: Oleic acid protects
saturated fatty acid mediated lipotoxicity in hepatocytes and rat
of non-alcoholic steatohepatitis. Life Sci. 203:291–304. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Sun J, Jin X and Li Y: Current strategies
for nonalcoholic fatty liver disease treatment (Review). Int J Mol
Med. 54:882024. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Tian C, Huang R and Xiang M: SIRT1:
Harnessing multiple pathways to hinder NAFLD. Pharmacol Res.
203:1071552024. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Smith BK, Marcinko K, Desjardins EM, Lally
JS, Ford RJ and Steinberg GR: Treatment of nonalcoholic fatty liver
disease: Role of AMPK. Am J Physiol Endocrinol Metab.
311:E730–E740. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Liu Q, Liu S, Chen L, Zhao Z, Du S, Dong
Q, Xin Y and Xuan S: Role and effective therapeutic target of gut
microbiota in NAFLD/NASH. Exp Ther Med. 18:1935–1944.
2019.PubMed/NCBI
|
|
73
|
Kim SE, Min JS, Lee S, Lee DY and Choi D:
Different effects of menopausal hormone therapy on non-alcoholic
fatty liver disease based on the route of estrogen administration.
Sci Rep. 13:154612023. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Keskin M, Hayıroğlu Mİ, Uzun AO, Güvenç
TS, Şahin S and Kozan Ö: Effect of nonalcoholic fatty liver disease
on in-hospital and long-term outcomes in patients with ST-segment
elevation myocardial infarction. Am J Cardiol. 120:1720–1726. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Şaylık F, Çınar T and Hayıroğlu Mİ: Effect
of the obesity paradox on mortality in patients with acute coronary
syndrome: A comprehensive meta-analysis of the literature. Balkan
Med J. 40:93–103. 2023. View Article : Google Scholar : PubMed/NCBI
|
